PRIME-ROSE brings together 28 partners, including ten beneficiaries and eighteen associated partners, from altogether 19 European countries. Professor Kjetil Taskén, Head of Institute for Cancer Research at Oslo University Hospital in Norway is the coordinator of PRIME-ROSE. Prof Hans Gelderblom, Leiden University Medical Center, is co-coordinator.
Oslo University Hospital, Oslo, Norway (Coordinating Partner)
Leiden University Medical Center (LUMC), Leiden, The Netherlands (Co-coordinating Partner)
Stockholm School of Economics Institute for Research (SIR), Stockholm, Sweden
Capital Region, Copenhagen, Denmark
Helsinki University Hospital, Helsinki, Finland
Centre Leon Berard, Lyon, France
Instituto Português de Oncologia do Porto FG, EPE (IPO-Porto), Porto, Portugal
Region Uppsala, Uppsala, Sweden
The Swedish Institute for Health Economics, Stockholm, Sweden
The Netherlands Cancer Institute (NIK), Amsterdam, Netherlands
Karolinska Institutet, Stockholm, Sweden
Region Skåne, Sweden
Heidelberg University Hospital, Heidelberg, Germany
Maria Sklodowska-Curie Institute of Oncology, Warsaw, Poland
University Hospital of Split (KBC Split), Split, Croatia
Tartu University Hospital, Tartu, Estonia
National Institute of Oncology, Budapest, Hungary
Vall D’Hebron Institute of Oncology, Barcelona, Spain
Center for Personalized Cancer Treatment hosted by Radboud University Medical Center, The Netherlands
National Cancer Institute, Vilnius, Lithuania
Cancer Research UK, London, UK
University of Manchester, Manchester, UK
Trinity College Dublin, Dublin, Ireland
Masaryk Memorial Cancer Institute (MOU), Brno, Czech Republic
Center for Innovation in Medicine (CIM), Bucharest, Romania
Istituto Europeo di Oncologia (IEO), Milan, Italy
Centrul de Oncologie “Sf. Nectarie”, Craiova, Romania
Sahlgrenska University Hospital, Gothenburg, Sweden
